Cargando…
Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome
PURPOSE: A new cross-linked hyaluronic acid (xlHA) gel occlusive device was assessed for safety and efficacy in the treatment of dry eyes. METHODS: This was an institutional review board-approved, single-site, open-label, prospective study to assess the efficacy and safety of placing the xlHA gel in...
Autor principal: | Fezza, John P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231461/ https://www.ncbi.nlm.nih.gov/pubmed/30510396 http://dx.doi.org/10.2147/OPTH.S187963 |
Ejemplares similares
-
Cohesive Polydensified Matrix(®) cross-linked hyaluronic acid volumizing gel: a magnetic resonance imaging and computed tomography study
por: Micheels, P, et al.
Publicado: (2018) -
Hyaluronic acid in the treatment of dry eye disease
por: Hynnekleiv, Leif, et al.
Publicado: (2022) -
A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome
por: Yang, Yun-Jung, et al.
Publicado: (2021) -
Hyaluronic Acid Fillers and ASIA Syndrome: Case Studies
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2023) -
Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease
por: Calonge, Margarita, et al.
Publicado: (2022)